Ram Kumar 
Anlon Healthcare IPO GMP Update (29 August 2023)
The Grey Market Premium (GMP) of Anlon Healthcare IPO has been stable at ₹6 per share over the last four consecutive sessions (26th to 29th August 2023). According to the latest market observations, the “subject to sauda” value is reported at ₹600, while no Kostak rates have been quoted yet.
Day-by-Day Anlon Healthcare IPO GMP Trend
- 29 August – ₹6 GMP | Subject to: ₹600
- 28 August – ₹6 GMP | Subject to: ₹600
- 27 August – ₹6 GMP | Subject to: ₹600
- 26 August – ₹6 GMP | Subject to: ₹600
- Before 25 August – No GMP activity reported
This indicates that investor sentiment in the grey market has remained positive but steady for the last few days. Even though the GMP is not significantly high, the consistent demand reflects a mildly bullish outlook among grey market traders.
What This Means for Investors
Grey Market Premium is often seen as an early indicator of listing gains. However, a GMP of ₹6 shows that while there is interest, the expected listing gain may remain limited unless demand picks up closer to the listing date. Investors should also note that GMP is an unofficial and unregulated market indicator and does not guarantee actual performance on the stock exchange.
Key Highlights
- IPO Name: Anlon Healthcare IPO
- Latest GMP: ₹6
- Kostak Rate: Not Available
- Subject to Sauda: ₹600
- Trend: Stable to Positive
Conclusion
The Anlon Healthcare IPO has drawn attention in the grey market, maintaining a steady GMP at ₹6. While this suggests modest demand, the final subscription figures and overall market conditions will play a critical role in determining the listing performance.
Disclaimer:- The Grey Market Premium (GMP) is an informal market indicator and should not be considered as investment advice. IPO investments are subject to market risks, and investors are advised to evaluate official financial documents, consult with certified advisors, and make independent decisions before applying for any IPO.
Author Bio
